Comprehensive Opioid Management in Patient Aligned Care Teams
Status: | Not yet recruiting |
---|---|
Conditions: | Chronic Pain, Chronic Pain |
Therapuetic Areas: | Musculoskeletal |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/12/2016 |
Start Date: | October 2015 |
End Date: | January 2018 |
Contact: | Rebecca A Czlapinski, M.A. |
Email: | rebecca.czlapinski@va.gov |
Phone: | 203-932-5711 |
This study is a randomized, controlled, multi-site, trial of a technology supported
treatment program called COMPACT relative to enhanced usual care (EUC). Because the
treatment is delivered via an automated system it is highly consistent and transferable,
thereby reducing variability in care and dependence on the availability of staff with
extensive training in evidence- based self-management for chronic pain. If successful, this
trial would provide a template for using telehealth technology to provide a comprehensive,
accessible, patient- centered care program that could be translated to other chronic
conditions.We will test for between group differences in physical functioning (primary
outcome) as well as pain intensity, health related quality of life, and emotional
functioning (secondary outcomes).
Hypothesis 1: Veterans with chronic pain randomized to IVR-CBT will report, relative to
those receiving EUC, improvements in physical functioning, decreases in pain intensity,
improvements in emotional functioning and health-related quality of life, and will
demonstrate lower treatment dropout rates and report higher treatment satisfaction at
post-treatment (12 weeks) and follow-up (24 and 36 weeks).
treatment program called COMPACT relative to enhanced usual care (EUC). Because the
treatment is delivered via an automated system it is highly consistent and transferable,
thereby reducing variability in care and dependence on the availability of staff with
extensive training in evidence- based self-management for chronic pain. If successful, this
trial would provide a template for using telehealth technology to provide a comprehensive,
accessible, patient- centered care program that could be translated to other chronic
conditions.We will test for between group differences in physical functioning (primary
outcome) as well as pain intensity, health related quality of life, and emotional
functioning (secondary outcomes).
Hypothesis 1: Veterans with chronic pain randomized to IVR-CBT will report, relative to
those receiving EUC, improvements in physical functioning, decreases in pain intensity,
improvements in emotional functioning and health-related quality of life, and will
demonstrate lower treatment dropout rates and report higher treatment satisfaction at
post-treatment (12 weeks) and follow-up (24 and 36 weeks).
OBJECTIVES: The objectives of the study are to: 1) test the effectiveness of COMPACT for
improving pain-relevant outcomes including physical functioning and pain intensity; 2)
determine whether opioid monitoring promotes guideline concordant care; and 3) examine key
components of the intervention process to inform future implementation.
RESEARCH DESIGN: This study is a randomized, controlled, multi-site, 2x2 factorial design
trial of a technology supported treatment program called COMPACT relative to enhanced usual
care (EUC).
METHODOLOGY: Participants will include 380 Veterans receiving COT and reporting chronic
musculoskeletal pain of at least moderate severity. Enrolled participants will be randomized
in a 1:1:1:1 ratio to one of the four treatment arms 1) IVR-CBT plus opioid monitoring, 2)
IVR-CBT, 3) opioid monitoring, and 4) enhanced usual care. COMPACT treatment contains two
elements; telephone CBT and automated, monthly opioid monitoring. In telephone CBT
participants will learn a series of pain self-management skills via a patient handbook
supplemented with weekly telephone calls from a nurse case manager. Opioid monitoring will
include monthly automated telephone calls which will assess opioid adherence, safety, and
pain treatment effectiveness. At baseline, 12 weeks (post-treatment), 24 weeks (follow-up)
and 36 weeks (follow-up) all participants will undergo an assessment of all outcome
variables.
improving pain-relevant outcomes including physical functioning and pain intensity; 2)
determine whether opioid monitoring promotes guideline concordant care; and 3) examine key
components of the intervention process to inform future implementation.
RESEARCH DESIGN: This study is a randomized, controlled, multi-site, 2x2 factorial design
trial of a technology supported treatment program called COMPACT relative to enhanced usual
care (EUC).
METHODOLOGY: Participants will include 380 Veterans receiving COT and reporting chronic
musculoskeletal pain of at least moderate severity. Enrolled participants will be randomized
in a 1:1:1:1 ratio to one of the four treatment arms 1) IVR-CBT plus opioid monitoring, 2)
IVR-CBT, 3) opioid monitoring, and 4) enhanced usual care. COMPACT treatment contains two
elements; telephone CBT and automated, monthly opioid monitoring. In telephone CBT
participants will learn a series of pain self-management skills via a patient handbook
supplemented with weekly telephone calls from a nurse case manager. Opioid monitoring will
include monthly automated telephone calls which will assess opioid adherence, safety, and
pain treatment effectiveness. At baseline, 12 weeks (post-treatment), 24 weeks (follow-up)
and 36 weeks (follow-up) all participants will undergo an assessment of all outcome
variables.
Inclusion Criteria:
- presence of at least moderate non-cancer, non-headache pain (i.e., pain scores of ≥ 4
as measured by the Numeric Rating Scale) for a period of ≥ 3 months;
- receipt of chronic opioid therapy as defined by ≥ 90 continuous days out of any 104
day period in the prior 12 month;
- ability to participate safely in the walking portion of the intervention as evidenced
by ability to walk at least one block;
- availability of a land line or cellular telephone
Exclusion Criteria:
- active psychosis or suicidality that could impair participation as defined by their
response during the baseline assessment interview (e.g., presence of suicidal intent
or uncontrolled psychotic symptoms). Presence of suicidal ideation or intent will
require immediate psychiatric attention to assure safety and institution of
appropriate treatment;
- life threatening or acute medical condition that could impair participation;
- dementia defined by a score of 20 or greater on the St. Louis University Mental
Status;
- sensory deficits that would impair participation (e.g., hearing loss to a degree that
telephone usage is not possible
We found this trial at
3
sites
VA Connecticut Healthcare System VA Connecticut encompasses an inpatient facility and Ambulatory Care Center in...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials